Please login to the form below

Not currently logged in
Email:
Password:

Briviact

This page shows the latest Briviact news and features for those working in and with pharma, biotech and healthcare.

UCB’s antiepileptic drug gains new US indication

UCB’s antiepileptic drug gains new US indication

UCB’ s antiepileptic drug gains new US indication. FDA approves Briviact as a monotherapy to treat POS. ... The US Food and Drug Administration (FDA) has approved UCB’s Briviact (brivaracetam) CV as a monotherapy treatment option for epilepsy

Latest news

  • SMC gives green light for BMS’ Opdivo SMC gives green light for BMS’ Opdivo

    2014. Additionally, the SMC gave three further approvals to Lundbeck's antidepressant Brintellix (vortioxetine), Novartis' Cosentyx (secukinumab) for ankylosing spondylitis, and UCB's Briviact (brivaracetam) for partial-onset seizures in epilepsy

  • UCB bags FDA approval for epilepsy drug Briviact UCB bags FDA approval for epilepsy drug Briviact

    Billy Dunn, director of the FDA's division of neurology products, said Briviact provides a welcome new treatment option for epilepsy patients. ... The recommended starting dose of Briviact is 50mg or 100mg a day, with a maintenance dose of 50mg to 200mg.

  • UCB wins European approval for epilepsy drug Briviact UCB wins European approval for epilepsy drug Briviact

    UCB wins European approval for epilepsy drug Briviact. Plans first launches within weeks. ... Briviact was submitted for approval in the US in January 2015 but remains under review by the FDA.

More from news
Approximately 3 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics